Crespo Cruz, ADel Boz, JRomero Gómez, C2023-02-092023-02-092020-10-27http://hdl.handle.net/10668/16506enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/DermatomyositisHumansPiperidinesPyrimidinesPyrrolesGood Response to Tofacitinib in Refractory Amyopathic Dermatomyositis.Dermatomiositis amiopática refractaria con buena respuesta a tofacitinib.research article33127420open access10.1016/j.ad.2019.07.0162173-5778https://doi.org/10.1016/j.ad.2019.07.016